Luke's patients in those years and speaking glowingly of them in HeartWare's corporate press releases. "There were patients who walked into the hospital for an elective measurement of the pressures in their heart Smart said. He didn't know, until told by a reporter, that a couple of years after he left,. Luke's nurse alleged that Frazier allowed a researcher who was not licensed to practice medicine in Texas to treat heart failure patients in his program. Frazier said he doesn't know which companies paid for his travel or consulting fees. He took pride in small changes he made to improve patient care. Sometimes, Smart and other cardiologists resorted to "hiding patients" moving them to other parts of the hospital to prevent Frazier from recommending experimental lvads, buying the patients time to recover with less invasive treatments or receive a transplant instead.
As for Young, the Cleveland cardiologist who found problems in the program, Frazier said he "was always jealous." Berg noted that Young has subsequently praised Frazier's contributions to the field. Luke's reported the research violations, some cardiologists at Texas Heart Institute were concerned about another aspect of the HeartMate II study. Frazier dismissed the orders as record-keeping errors and blamed others for the mistakes, according to a partial transcript of the deposition filed in court. Luke's Episcopal Hospital in 2013. The litigation dragged on for more than a decade, with little publicity. In a written response to questions, Frazier praised Smart as an "excellent director" and said if Smart had concerns about the program, "he never expressed them." He said he and Smart both "were trying to do the best we could for the patients. He said he could have cashed in on his work with medical device makers, but he never did. ( See how we conducted our analysis.) Frazier took issue with ProPublica's analysis, saying it was "grossly unfair" to focus only on Medicare patients rather than the larger pool of patients the hospital treats, though he did not provide data showing his overall outcomes. Frazier, right, takes questions from the media at a 1991 press conference weeks after implanting the worlds first portable left-ventricular assist device into a patient, pictured far left. If he had had the modern view, this field wouldn't exist, and tens of thousands of patients wouldn't be alive.". But when those studies were published in 20, Frazier disclosed no conflicts, even as some of his fellow authors did. "Bud" Frazier has obsessively pursued that goal, contributing to many breakthroughs in the long and unfinished effort to develop a permanent mechanical replacement for the human heart.